NexImmune Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins January 2, 2018
Read More
Read news items items specific to Ponce Therapeutics or about other Rapha Capital-related entities. Also see scientific articles detailing the rapid advances in the important science of anti-aging
NexImmune Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins January 2, 2018
NuMat Technologies, Inc Versum Materials and NuMat Technologies to Commercialize Next-Generation Adsorbent Technology for Delivery of Dopant Gases The ION-X® technology platform enables IC manufacturers to meet increasingly demanding performance…